ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
XRP trades around $1.40 with a market cap near $87B. Reaching $20 would require a multi-trillion dollar shift in dema...
Stocks opened sharply lower on May 15, 2026, pushing the S&P 500 onto a heavier red backdrop as tech weakness and inf...
Ethereum stabilizes around $2,100 as real-world asset tokenization accelerates, driving ETH-led growth in the RWA sec...
Markets shift as the White House cools its push for rate cuts while Kevin Warsh faces inflation constraints. The 10-y...
An Australian-born fast-casual chain that once eyed a nationwide U.S. footprint has abruptly shut down all U.S. locat...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
Mortgage rates stay elevated due to tariff-driven inflation, delaying refinances and new purchases. The Fed has signa...
KORU, a triple-leveraged bet on South Korea stocks, sank 42% in a single trading day as chipmakers slid and risk appe...
Noble Black & Partners posted $546.03 million in 2025 sales across 220 sides, moved to CORCORAN in September 2025, an...
President Trump cancels planned Iran strikes, unleashing a rapid response in crypto and energy markets. Bitcoin jumps...
Oil’s 5.7% weekly drop is fueling a rotation into jet, materials, and infrastructure plays as traders reassess fuel c...